Imperva Inc (IMPV): Billionaire Paul Singer’s Elliott Reveals New Stake

Page 9 of 13

Page 9 of 13 – SEC Filing
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
Elliott, through The Liverpool Limited Partnership, a Bermuda limited partnership and a wholly-owned subsidiary of Elliott (“Liverpool”), and Elliott International have entered into notional principal amount derivative agreements (the “Derivative Agreements”) in the form of cash settled swaps with respect to 313,500 and 636,500 shares of Common Stock of the Issuer, respectively (representing economic exposure comparable to approximately 1.0% and 2.0% of the shares of Common Stock of the Issuer, respectively). Collectively, the Derivative Agreements held by the Reporting Persons represent economic exposure comparable to an interest in approximately 2.9% of the shares of Common Stock. The Derivative Agreements provide Elliott and Elliott International with economic results that are comparable to the economic results of ownership but do not provide them with the power to vote or direct the voting or dispose of or direct the disposition of the shares that are referenced in the Derivative Agreements (such shares, the “Subject Shares”). The Reporting Persons disclaim beneficial ownership in the Subject Shares. The counterparties to the Derivative Agreements are unaffiliated third party financial institutions.
Elliott has sold to counterparties put options that provide the counterparty the right to put to Elliott up to 68,600 shares of Common Stock at a price of $40 per share, if such right is exercised prior to or on July 16, 2016.
Elliott International has sold to counterparties put options that provide the counterparty the right to put to Elliott International up to 139,300 shares of Common Stock at a price of $40 per share, if such right is exercised prior to or on July 16, 2016.
On June 20, 2016, Elliott, Elliott International and EICA entered into a Joint Filing Agreement (the “Joint Filing Agreement”) in which the parties agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached as an exhibit hereto and is incorporated herein by reference.
Except as described above in this Item 6, none of the Reporting Persons has any contracts, arrangements, understandings or relationships with respect to the securities of the Issuer.
Item 7. Material to be Filed as Exhibits.
Exhibit 99.1 – Joint Filing Agreement.
Schedule 1 – Transactions of the Reporting Persons Effected During the Past 60 Days.

Follow Imperva Inc (NYSE:IMPV)

Page 9 of 13